The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bipolar Disorder Drug Treatment Market Research Report 2024
Synopsis
Drug therapy is currently the core method of treating bipolar disorder, that is, the use of emotional stabilizers to adjust the patient's mood. Bipolar disorder is complex and difficult to control. The drug effect of emotional stabilizers can help patients to suppress their emotions when they are too high, to increase their emotions when they are depressed, to stabilize their emotions at a normal level, and to effectively prevent the recurrence of bipolar disorder. The quickest and most effective approach may be convulsive-free electroconvulsive therapy.
The global Bipolar Disorder Drug Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bipolar Disorder Drug Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bipolar Disorder Drug Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bipolar Disorder Drug Treatment include AbbVie Inc., Glaxo SmithKline (GSK), Eli Lily and Company, Janssen Pharmaceuticals, Johnson & Johnson, Astellas Pharma Inc, Bristol Myers Squibb, Gedeon Richter PLC. and H. Lundbeck A/S, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder Drug Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder Drug Treatment.
Report Scope
The Bipolar Disorder Drug Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bipolar Disorder Drug Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bipolar Disorder Drug Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
Glaxo SmithKline (GSK)
Eli Lily and Company
Janssen Pharmaceuticals
Johnson & Johnson
Astellas Pharma Inc
Bristol Myers Squibb
Gedeon Richter PLC.
H. Lundbeck A/S
Pfizer Inc.
Novartis AG
Otsuka Holdings Co. Ltd
Validus Pharmaceuticals LLC.
Segment by Type
Mood Stabilizers
Anticonvulsants
Antipsychotic Drugs
Antidepressant Drugs
Anti-Anxiety Drugs
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bipolar Disorder Drug Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bipolar Disorder Drug Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Drug therapy is currently the core method of treating bipolar disorder, that is, the use of emotional stabilizers to adjust the patient's mood. Bipolar disorder is complex and difficult to control. The drug effect of emotional stabilizers can help patients to suppress their emotions when they are too high, to increase their emotions when they are depressed, to stabilize their emotions at a normal level, and to effectively prevent the recurrence of bipolar disorder. The quickest and most effective approach may be convulsive-free electroconvulsive therapy.
The global Bipolar Disorder Drug Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bipolar Disorder Drug Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bipolar Disorder Drug Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bipolar Disorder Drug Treatment include AbbVie Inc., Glaxo SmithKline (GSK), Eli Lily and Company, Janssen Pharmaceuticals, Johnson & Johnson, Astellas Pharma Inc, Bristol Myers Squibb, Gedeon Richter PLC. and H. Lundbeck A/S, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder Drug Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder Drug Treatment.
Report Scope
The Bipolar Disorder Drug Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bipolar Disorder Drug Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bipolar Disorder Drug Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
Glaxo SmithKline (GSK)
Eli Lily and Company
Janssen Pharmaceuticals
Johnson & Johnson
Astellas Pharma Inc
Bristol Myers Squibb
Gedeon Richter PLC.
H. Lundbeck A/S
Pfizer Inc.
Novartis AG
Otsuka Holdings Co. Ltd
Validus Pharmaceuticals LLC.
Segment by Type
Mood Stabilizers
Anticonvulsants
Antipsychotic Drugs
Antidepressant Drugs
Anti-Anxiety Drugs
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bipolar Disorder Drug Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bipolar Disorder Drug Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bipolar Disorder Drug Treatment Market Overview
1.1 Product Overview and Scope of Bipolar Disorder Drug Treatment
1.2 Bipolar Disorder Drug Treatment Segment by Type
1.2.1 Global Bipolar Disorder Drug Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Mood Stabilizers
1.2.3 Anticonvulsants
1.2.4 Antipsychotic Drugs
1.2.5 Antidepressant Drugs
1.2.6 Anti-Anxiety Drugs
1.3 Bipolar Disorder Drug Treatment Segment by Application
1.3.1 Global Bipolar Disorder Drug Treatment Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Bipolar Disorder Drug Treatment Market Size Estimates and Forecasts
1.4.1 Global Bipolar Disorder Drug Treatment Revenue 2019-2030
1.4.2 Global Bipolar Disorder Drug Treatment Sales 2019-2030
1.4.3 Global Bipolar Disorder Drug Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bipolar Disorder Drug Treatment Market Competition by Manufacturers
2.1 Global Bipolar Disorder Drug Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bipolar Disorder Drug Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bipolar Disorder Drug Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Bipolar Disorder Drug Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bipolar Disorder Drug Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bipolar Disorder Drug Treatment, Product Type & Application
2.7 Bipolar Disorder Drug Treatment Market Competitive Situation and Trends
2.7.1 Bipolar Disorder Drug Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bipolar Disorder Drug Treatment Players Market Share by Revenue
2.7.3 Global Bipolar Disorder Drug Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bipolar Disorder Drug Treatment Retrospective Market Scenario by Region
3.1 Global Bipolar Disorder Drug Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bipolar Disorder Drug Treatment Global Bipolar Disorder Drug Treatment Sales by Region: 2019-2030
3.2.1 Global Bipolar Disorder Drug Treatment Sales by Region: 2019-2024
3.2.2 Global Bipolar Disorder Drug Treatment Sales by Region: 2025-2030
3.3 Global Bipolar Disorder Drug Treatment Global Bipolar Disorder Drug Treatment Revenue by Region: 2019-2030
3.3.1 Global Bipolar Disorder Drug Treatment Revenue by Region: 2019-2024
3.3.2 Global Bipolar Disorder Drug Treatment Revenue by Region: 2025-2030
3.4 North America Bipolar Disorder Drug Treatment Market Facts & Figures by Country
3.4.1 North America Bipolar Disorder Drug Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bipolar Disorder Drug Treatment Sales by Country (2019-2030)
3.4.3 North America Bipolar Disorder Drug Treatment Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bipolar Disorder Drug Treatment Market Facts & Figures by Country
3.5.1 Europe Bipolar Disorder Drug Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bipolar Disorder Drug Treatment Sales by Country (2019-2030)
3.5.3 Europe Bipolar Disorder Drug Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Bipolar Disorder Drug Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Bipolar Disorder Drug Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bipolar Disorder Drug Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Bipolar Disorder Drug Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Bipolar Disorder Drug Treatment Market Facts & Figures by Country
3.7.1 Latin America Bipolar Disorder Drug Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bipolar Disorder Drug Treatment Sales by Country (2019-2030)
3.7.3 Latin America Bipolar Disorder Drug Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bipolar Disorder Drug Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Bipolar Disorder Drug Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bipolar Disorder Drug Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bipolar Disorder Drug Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bipolar Disorder Drug Treatment Sales by Type (2019-2030)
4.1.1 Global Bipolar Disorder Drug Treatment Sales by Type (2019-2024)
4.1.2 Global Bipolar Disorder Drug Treatment Sales by Type (2025-2030)
4.1.3 Global Bipolar Disorder Drug Treatment Sales Market Share by Type (2019-2030)
4.2 Global Bipolar Disorder Drug Treatment Revenue by Type (2019-2030)
4.2.1 Global Bipolar Disorder Drug Treatment Revenue by Type (2019-2024)
4.2.2 Global Bipolar Disorder Drug Treatment Revenue by Type (2025-2030)
4.2.3 Global Bipolar Disorder Drug Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Bipolar Disorder Drug Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bipolar Disorder Drug Treatment Sales by Application (2019-2030)
5.1.1 Global Bipolar Disorder Drug Treatment Sales by Application (2019-2024)
5.1.2 Global Bipolar Disorder Drug Treatment Sales by Application (2025-2030)
5.1.3 Global Bipolar Disorder Drug Treatment Sales Market Share by Application (2019-2030)
5.2 Global Bipolar Disorder Drug Treatment Revenue by Application (2019-2030)
5.2.1 Global Bipolar Disorder Drug Treatment Revenue by Application (2019-2024)
5.2.2 Global Bipolar Disorder Drug Treatment Revenue by Application (2025-2030)
5.2.3 Global Bipolar Disorder Drug Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Bipolar Disorder Drug Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie Inc.
6.1.1 AbbVie Inc. Corporation Information
6.1.2 AbbVie Inc. Description and Business Overview
6.1.3 AbbVie Inc. Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Inc. Bipolar Disorder Drug Treatment Product Portfolio
6.1.5 AbbVie Inc. Recent Developments/Updates
6.2 Glaxo SmithKline (GSK)
6.2.1 Glaxo SmithKline (GSK) Corporation Information
6.2.2 Glaxo SmithKline (GSK) Description and Business Overview
6.2.3 Glaxo SmithKline (GSK) Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Glaxo SmithKline (GSK) Bipolar Disorder Drug Treatment Product Portfolio
6.2.5 Glaxo SmithKline (GSK) Recent Developments/Updates
6.3 Eli Lily and Company
6.3.1 Eli Lily and Company Corporation Information
6.3.2 Eli Lily and Company Description and Business Overview
6.3.3 Eli Lily and Company Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lily and Company Bipolar Disorder Drug Treatment Product Portfolio
6.3.5 Eli Lily and Company Recent Developments/Updates
6.4 Janssen Pharmaceuticals
6.4.1 Janssen Pharmaceuticals Corporation Information
6.4.2 Janssen Pharmaceuticals Description and Business Overview
6.4.3 Janssen Pharmaceuticals Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Janssen Pharmaceuticals Bipolar Disorder Drug Treatment Product Portfolio
6.4.5 Janssen Pharmaceuticals Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Bipolar Disorder Drug Treatment Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Astellas Pharma Inc
6.6.1 Astellas Pharma Inc Corporation Information
6.6.2 Astellas Pharma Inc Description and Business Overview
6.6.3 Astellas Pharma Inc Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Astellas Pharma Inc Bipolar Disorder Drug Treatment Product Portfolio
6.6.5 Astellas Pharma Inc Recent Developments/Updates
6.7 Bristol Myers Squibb
6.6.1 Bristol Myers Squibb Corporation Information
6.6.2 Bristol Myers Squibb Description and Business Overview
6.6.3 Bristol Myers Squibb Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol Myers Squibb Bipolar Disorder Drug Treatment Product Portfolio
6.7.5 Bristol Myers Squibb Recent Developments/Updates
6.8 Gedeon Richter PLC.
6.8.1 Gedeon Richter PLC. Corporation Information
6.8.2 Gedeon Richter PLC. Description and Business Overview
6.8.3 Gedeon Richter PLC. Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Gedeon Richter PLC. Bipolar Disorder Drug Treatment Product Portfolio
6.8.5 Gedeon Richter PLC. Recent Developments/Updates
6.9 H. Lundbeck A/S
6.9.1 H. Lundbeck A/S Corporation Information
6.9.2 H. Lundbeck A/S Description and Business Overview
6.9.3 H. Lundbeck A/S Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 H. Lundbeck A/S Bipolar Disorder Drug Treatment Product Portfolio
6.9.5 H. Lundbeck A/S Recent Developments/Updates
6.10 Pfizer Inc.
6.10.1 Pfizer Inc. Corporation Information
6.10.2 Pfizer Inc. Description and Business Overview
6.10.3 Pfizer Inc. Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Inc. Bipolar Disorder Drug Treatment Product Portfolio
6.10.5 Pfizer Inc. Recent Developments/Updates
6.11 Novartis AG
6.11.1 Novartis AG Corporation Information
6.11.2 Novartis AG Bipolar Disorder Drug Treatment Description and Business Overview
6.11.3 Novartis AG Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novartis AG Bipolar Disorder Drug Treatment Product Portfolio
6.11.5 Novartis AG Recent Developments/Updates
6.12 Otsuka Holdings Co. Ltd
6.12.1 Otsuka Holdings Co. Ltd Corporation Information
6.12.2 Otsuka Holdings Co. Ltd Bipolar Disorder Drug Treatment Description and Business Overview
6.12.3 Otsuka Holdings Co. Ltd Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Otsuka Holdings Co. Ltd Bipolar Disorder Drug Treatment Product Portfolio
6.12.5 Otsuka Holdings Co. Ltd Recent Developments/Updates
6.13 Validus Pharmaceuticals LLC.
6.13.1 Validus Pharmaceuticals LLC. Corporation Information
6.13.2 Validus Pharmaceuticals LLC. Bipolar Disorder Drug Treatment Description and Business Overview
6.13.3 Validus Pharmaceuticals LLC. Bipolar Disorder Drug Treatment Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Validus Pharmaceuticals LLC. Bipolar Disorder Drug Treatment Product Portfolio
6.13.5 Validus Pharmaceuticals LLC. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bipolar Disorder Drug Treatment Industry Chain Analysis
7.2 Bipolar Disorder Drug Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bipolar Disorder Drug Treatment Production Mode & Process
7.4 Bipolar Disorder Drug Treatment Sales and Marketing
7.4.1 Bipolar Disorder Drug Treatment Sales Channels
7.4.2 Bipolar Disorder Drug Treatment Distributors
7.5 Bipolar Disorder Drug Treatment Customers
8 Bipolar Disorder Drug Treatment Market Dynamics
8.1 Bipolar Disorder Drug Treatment Industry Trends
8.2 Bipolar Disorder Drug Treatment Market Drivers
8.3 Bipolar Disorder Drug Treatment Market Challenges
8.4 Bipolar Disorder Drug Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bipolar Disorder Drug Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bipolar Disorder Drug Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bipolar Disorder Drug Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bipolar Disorder Drug Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Bipolar Disorder Drug Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bipolar Disorder Drug Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bipolar Disorder Drug Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bipolar Disorder Drug Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bipolar Disorder Drug Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bipolar Disorder Drug Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bipolar Disorder Drug Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Bipolar Disorder Drug Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bipolar Disorder Drug Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Drug Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bipolar Disorder Drug Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bipolar Disorder Drug Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Bipolar Disorder Drug Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Bipolar Disorder Drug Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Bipolar Disorder Drug Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Bipolar Disorder Drug Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bipolar Disorder Drug Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Bipolar Disorder Drug Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bipolar Disorder Drug Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Bipolar Disorder Drug Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bipolar Disorder Drug Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Bipolar Disorder Drug Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Bipolar Disorder Drug Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bipolar Disorder Drug Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bipolar Disorder Drug Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bipolar Disorder Drug Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Bipolar Disorder Drug Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Bipolar Disorder Drug Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bipolar Disorder Drug Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bipolar Disorder Drug Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bipolar Disorder Drug Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Bipolar Disorder Drug Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Bipolar Disorder Drug Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bipolar Disorder Drug Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bipolar Disorder Drug Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bipolar Disorder Drug Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Bipolar Disorder Drug Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Bipolar Disorder Drug Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bipolar Disorder Drug Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bipolar Disorder Drug Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bipolar Disorder Drug Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Bipolar Disorder Drug Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Bipolar Disorder Drug Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bipolar Disorder Drug Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bipolar Disorder Drug Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Bipolar Disorder Drug Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Bipolar Disorder Drug Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Bipolar Disorder Drug Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Bipolar Disorder Drug Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bipolar Disorder Drug Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bipolar Disorder Drug Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Bipolar Disorder Drug Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Bipolar Disorder Drug Treatment Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bipolar Disorder Drug Treatment Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bipolar Disorder Drug Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Bipolar Disorder Drug Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Bipolar Disorder Drug Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Bipolar Disorder Drug Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Bipolar Disorder Drug Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bipolar Disorder Drug Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bipolar Disorder Drug Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Bipolar Disorder Drug Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Bipolar Disorder Drug Treatment Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bipolar Disorder Drug Treatment Price (US$/Unit) by Application (2025-2030)
Table 70. AbbVie Inc. Corporation Information
Table 71. AbbVie Inc. Description and Business Overview
Table 72. AbbVie Inc. Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Inc. Bipolar Disorder Drug Treatment Product
Table 74. AbbVie Inc. Recent Developments/Updates
Table 75. Glaxo SmithKline (GSK) Corporation Information
Table 76. Glaxo SmithKline (GSK) Description and Business Overview
Table 77. Glaxo SmithKline (GSK) Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Glaxo SmithKline (GSK) Bipolar Disorder Drug Treatment Product
Table 79. Glaxo SmithKline (GSK) Recent Developments/Updates
Table 80. Eli Lily and Company Corporation Information
Table 81. Eli Lily and Company Description and Business Overview
Table 82. Eli Lily and Company Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lily and Company Bipolar Disorder Drug Treatment Product
Table 84. Eli Lily and Company Recent Developments/Updates
Table 85. Janssen Pharmaceuticals Corporation Information
Table 86. Janssen Pharmaceuticals Description and Business Overview
Table 87. Janssen Pharmaceuticals Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Janssen Pharmaceuticals Bipolar Disorder Drug Treatment Product
Table 89. Janssen Pharmaceuticals Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Johnson & Johnson Bipolar Disorder Drug Treatment Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Astellas Pharma Inc Corporation Information
Table 96. Astellas Pharma Inc Description and Business Overview
Table 97. Astellas Pharma Inc Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Astellas Pharma Inc Bipolar Disorder Drug Treatment Product
Table 99. Astellas Pharma Inc Recent Developments/Updates
Table 100. Bristol Myers Squibb Corporation Information
Table 101. Bristol Myers Squibb Description and Business Overview
Table 102. Bristol Myers Squibb Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bristol Myers Squibb Bipolar Disorder Drug Treatment Product
Table 104. Bristol Myers Squibb Recent Developments/Updates
Table 105. Gedeon Richter PLC. Corporation Information
Table 106. Gedeon Richter PLC. Description and Business Overview
Table 107. Gedeon Richter PLC. Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Gedeon Richter PLC. Bipolar Disorder Drug Treatment Product
Table 109. Gedeon Richter PLC. Recent Developments/Updates
Table 110. H. Lundbeck A/S Corporation Information
Table 111. H. Lundbeck A/S Description and Business Overview
Table 112. H. Lundbeck A/S Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. H. Lundbeck A/S Bipolar Disorder Drug Treatment Product
Table 114. H. Lundbeck A/S Recent Developments/Updates
Table 115. Pfizer Inc. Corporation Information
Table 116. Pfizer Inc. Description and Business Overview
Table 117. Pfizer Inc. Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Pfizer Inc. Bipolar Disorder Drug Treatment Product
Table 119. Pfizer Inc. Recent Developments/Updates
Table 120. Novartis AG Corporation Information
Table 121. Novartis AG Description and Business Overview
Table 122. Novartis AG Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Novartis AG Bipolar Disorder Drug Treatment Product
Table 124. Novartis AG Recent Developments/Updates
Table 125. Otsuka Holdings Co. Ltd Corporation Information
Table 126. Otsuka Holdings Co. Ltd Description and Business Overview
Table 127. Otsuka Holdings Co. Ltd Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Otsuka Holdings Co. Ltd Bipolar Disorder Drug Treatment Product
Table 129. Otsuka Holdings Co. Ltd Recent Developments/Updates
Table 130. Validus Pharmaceuticals LLC. Corporation Information
Table 131. Validus Pharmaceuticals LLC. Description and Business Overview
Table 132. Validus Pharmaceuticals LLC. Bipolar Disorder Drug Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Validus Pharmaceuticals LLC. Bipolar Disorder Drug Treatment Product
Table 134. Validus Pharmaceuticals LLC. Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Bipolar Disorder Drug Treatment Distributors List
Table 138. Bipolar Disorder Drug Treatment Customers List
Table 139. Bipolar Disorder Drug Treatment Market Trends
Table 140. Bipolar Disorder Drug Treatment Market Drivers
Table 141. Bipolar Disorder Drug Treatment Market Challenges
Table 142. Bipolar Disorder Drug Treatment Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bipolar Disorder Drug Treatment
Figure 2. Global Bipolar Disorder Drug Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bipolar Disorder Drug Treatment Market Share by Type in 2023 & 2030
Figure 4. Mood Stabilizers Product Picture
Figure 5. Anticonvulsants Product Picture
Figure 6. Antipsychotic Drugs Product Picture
Figure 7. Antidepressant Drugs Product Picture
Figure 8. Anti-Anxiety Drugs Product Picture
Figure 9. Global Bipolar Disorder Drug Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Bipolar Disorder Drug Treatment Market Share by Application in 2023 & 2030
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Global Bipolar Disorder Drug Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Bipolar Disorder Drug Treatment Market Size (2019-2030) & (US$ Million)
Figure 15. Global Bipolar Disorder Drug Treatment Sales (2019-2030) & (K Units)
Figure 16. Global Bipolar Disorder Drug Treatment Average Price (US$/Unit) & (2019-2030)
Figure 17. Bipolar Disorder Drug Treatment Report Years Considered
Figure 18. Bipolar Disorder Drug Treatment Sales Share by Manufacturers in 2023
Figure 19. Global Bipolar Disorder Drug Treatment Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Bipolar Disorder Drug Treatment Players: Market Share by Revenue in 2023
Figure 21. Bipolar Disorder Drug Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Bipolar Disorder Drug Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Bipolar Disorder Drug Treatment Sales Market Share by Country (2019-2030)
Figure 24. North America Bipolar Disorder Drug Treatment Revenue Market Share by Country (2019-2030)
Figure 25. United States Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Bipolar Disorder Drug Treatment Sales Market Share by Country (2019-2030)
Figure 28. Europe Bipolar Disorder Drug Treatment Revenue Market Share by Country (2019-2030)
Figure 29. Germany Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Netherlands Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Bipolar Disorder Drug Treatment Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Bipolar Disorder Drug Treatment Revenue Market Share by Region (2019-2030)
Figure 36. China Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Bipolar Disorder Drug Treatment Sales Market Share by Country (2019-2030)
Figure 44. Latin America Bipolar Disorder Drug Treatment Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Bipolar Disorder Drug Treatment Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Bipolar Disorder Drug Treatment Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Bipolar Disorder Drug Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Bipolar Disorder Drug Treatment by Type (2019-2030)
Figure 54. Global Revenue Market Share of Bipolar Disorder Drug Treatment by Type (2019-2030)
Figure 55. Global Bipolar Disorder Drug Treatment Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Bipolar Disorder Drug Treatment by Application (2019-2030)
Figure 57. Global Revenue Market Share of Bipolar Disorder Drug Treatment by Application (2019-2030)
Figure 58. Global Bipolar Disorder Drug Treatment Price (US$/Unit) by Application (2019-2030)
Figure 59. Bipolar Disorder Drug Treatment Value Chain
Figure 60. Bipolar Disorder Drug Treatment Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
